Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I Stable (no update expected for reasons given in 'What's new')
Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I Stable (no update expected for reasons given in 'What's new') is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Enzyme Replacement Therapy With Laronidase (Aldurazyme®) for Treating Mucopolysaccharidosis Type I Stable (no Update Expected for Reasons Given in 'What's New')." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431402/all/Enzyme_replacement_therapy_with_laronidase__Aldurazyme��__for_treating_mucopolysaccharidosis_type_I_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed 05 February 2023.
Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I Stable (no update expected for reasons given in 'What's new'). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431402/all/Enzyme_replacement_therapy_with_laronidase__Aldurazyme��__for_treating_mucopolysaccharidosis_type_I_Stable__no_update_expected_for_reasons_given_in_'What's_new'_. Accessed February 5, 2023.
Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I Stable (no update expected for reasons given in 'What's new'). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431402/all/Enzyme_replacement_therapy_with_laronidase__Aldurazyme��__for_treating_mucopolysaccharidosis_type_I_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
Enzyme Replacement Therapy With Laronidase (Aldurazyme®) for Treating Mucopolysaccharidosis Type I Stable (no Update Expected for Reasons Given in 'What's New') [Internet]. In: Cochrane Abstracts. [cited 2023 February 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431402/all/Enzyme_replacement_therapy_with_laronidase__Aldurazyme��__for_treating_mucopolysaccharidosis_type_I_Stable__no_update_expected_for_reasons_given_in_'What's_new'_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type I Stable (no update expected for reasons given in 'What's new')
ID - 431402
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431402/all/Enzyme_replacement_therapy_with_laronidase__Aldurazyme��__for_treating_mucopolysaccharidosis_type_I_Stable__no_update_expected_for_reasons_given_in_'What's_new'_
DB - Evidence Central
DP - Unbound Medicine
ER -